Cargando…
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome
Down syndrome (DS), the genetic condition caused by trisomy 21 (T21), is characterized by stunted growth, cognitive impairment, and increased risk of diverse neurological conditions. Although signs of lifelong neurodegeneration are well documented in DS, the mechanisms underlying this phenotype awai...
Autores principales: | Araya, Paula, Kinning, Kohl T., Coughlan, Christina, Smith, Keith P., Granrath, Ross E., Enriquez-Estrada, Belinda A., Worek, Kayleigh, Sullivan, Kelly D., Rachubinski, Angela L., Wolter-Warmerdam, Kristine, Hickey, Francis, Galbraith, Matthew D., Potter, Huntington, Espinosa, Joaquin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876612/ https://www.ncbi.nlm.nih.gov/pubmed/36577365 http://dx.doi.org/10.1016/j.celrep.2022.111883 |
Ejemplares similares
-
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition
por: Galbraith, Matthew D., et al.
Publicado: (2023) -
JAK inhibition for treatment of psoriatic arthritis in Down syndrome
por: Pham, Andrew T., et al.
Publicado: (2021) -
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
por: Sullivan, Kelly D., et al.
Publicado: (2017) -
Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity
por: Araya, Paula, et al.
Publicado: (2019) -
Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
por: Rachubinski, Angela L., et al.
Publicado: (2019)